Commercially insured patients across the country pay widely varying amounts for the same procedure, the costs of which primarily are underwritten by employers.

The facilities account for half of employer plan spending, and Kaufman Hall figures show that they look better.

While the One Big Beautiful Bill Act (OBBBA) that President Trump signed into law on July 4, 2025, somewhat surprisingly does not directly address any issues related to qualified retirement plans, it does impact executive compensation in a couple of ways that may be of interest to executives and their financial advisors.

Only 38% said they trust their employer to act in their best interest when it comes to prescriptions.